US charges British ISIS militants

October 07, 2020

Player utilities

Two men are seated with one raising his hand to his face and a pair of handcuffs shown in soft focus in the nearground.

Alexanda Amon Kotey (left) and El Shafee Elsheikh, both from Britain, joined ISIS and were part of a cell that beheaded Western hostages, a law enforcement official alleged, March 30, 2018.

Credit:

Hussein Malla/AP/File photo

In the first case of its kind, two ISIS militants, formally British citizens, have been charged in a US court for their involvement in the beheading of American and British journalists and aid workers in Syria. And, a court in Greece has ruled that the far-right Golden Dawn party was operating as a criminal organization, delivering landmark guilty verdicts. Also, the EU Parliament has agreed to set a target of cutting carbon emissions 60% by 2030. It's an ambitious goal but still needs approval by the 27 EU member nations.

Music Heard On Air

Stories in this Edition

Top of The World

VP candidates set to debate in shadow of coronavirus; Nagorno-Karabakh conflict threatening region; Nobel Prize in Chemistry awarded

US Vice President Mike Pence and Sen. Kamala Harris, his Democratic challenger, will face off Wednesday night on the debate stage in Salt Lake City, Utah — separated by plexiglass and a distance of just over 12 feet. And, fighting in the South Caucasus region of Nagorno-Karabakh threatened to further engulf regional powers. Also, two women scientists have been awarded the Nobel chemistry prize for a gene-editing tool known as “molecular scissors” that could help cure inherited diseases.

Coronavirus Conversations

Discussion: What's driving the latest coronavirus surges?

Many health officials around the world are working to contain second waves of the coronavirus. As part of our regular series on the pandemic with Harvard's T.H. Chan School of Public Health, join us as we examine what's driving the latest wave of surges around the world. To find out more, The World's Elana Gordon moderated a discussion with Yonatan Grad, from Harvard's department of immunology and infectious diseases.